Medicine
Doxazosin 1 mg tablet
Doxazosin 1 mg tablet is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C…
Key facts
- Active ingredient (INN)
- Doxazosin
- Brand
- Sold under the generic name
- Strength
- 1 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 1000 tablets and 34 more
- Manufacturers
- Zydus LifesciencesIndiaUnichem LaboratoriesIndiaAccord HealthcareIndiaAurobindo PharmaIndiaAvet PharmaceuticalsIndiaBryant Ranch PrepackA-S Medication SolutionsAmerican Health PackagingApotexAvPAK
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted from 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C02CA04 Doxazosin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 18 October 2000
- Identifiers
- RxCUI 197625, 197626, 197627 +1DailyMed set ID 3354196f-bbcf-4bc5-94f6-e6e8e132acb1, 508b908e-8d80-422e-8ec0-2081185f4c95, 2830533c-ccdf-4401-b19c-763eeb1bc0a7 +20NDC 0904-5522, 16571-165, 16729-211 +20Application ANDA075580, ANDA212727, ANDA202824 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 68382-783-01 | Zydus LifesciencesIndia | 31 August 2017 |
| 30 tablet in 1 bottle | 68382-783-06 | Zydus LifesciencesIndia | 31 August 2017 |
| 1000 tablet in 1 bottle | 68382-783-10 | Zydus LifesciencesIndia | 31 August 2017 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 68382-783-77 | Zydus LifesciencesIndia | 31 August 2017 |
| 1000 tablet in 1 bottle | 70771-1112-0 | Zydus LifesciencesIndia | 31 August 2017 |
| 100 tablet in 1 bottle | 70771-1112-1 | Zydus LifesciencesIndia | 31 August 2017 |
| 30 tablet in 1 bottle | 70771-1112-3 | Zydus LifesciencesIndia | 31 August 2017 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 70771-1112-4 | Zydus LifesciencesIndia | 31 August 2017 |
| 100 tablet in 1 bottle | 16729-211-01 | Accord HealthcareIndia | 4 March 2015 |
| 1000 tablet in 1 bottle | 16729-211-17 | Accord HealthcareIndia | 30 June 2016 |
| 100 tablet in 1 bottle | 59651-892-01 | Aurobindo PharmaIndia | 1 March 2024 |
| 1000 tablet in 1 bottle | 59651-892-99 | Aurobindo PharmaIndia | 1 March 2024 |
| 100 tablet in 1 bottle | 23155-092-01 | Avet PharmaceuticalsIndia | 13 February 2018 |
| 100 tablet in 1 bottle | 29300-351-01 | Unichem LaboratoriesIndia | 15 March 2024 |
| 1000 tablet in 1 bottle | 29300-351-10 | Unichem LaboratoriesIndia | 15 March 2024 |
| 30 tablet in 1 bottle | 29300-351-13 | Unichem LaboratoriesIndia | 15 March 2024 |
| 100 tablet in 1 bottle | 60505-0093-0 | Apotex | 14 July 2011 |
| 1000 tablet in 1 bottle | 60505-0093-1 | Apotex | 14 July 2011 |
| 90 tablet in 1 bottle | 62135-051-90 | Chartwell RX | 6 June 2023 |
| 100 tablet in 1 bottle | 59762-1388-7 | Mylan Pharmaceuticals | 9 May 2025 |
| 100 tablet in 1 bottle | 16571-165-01 | Rising Pharma Holdings | 20 May 2024 |
| 100 tablet in 1 bottle | 0093-2070-01 | Teva Pharmaceuticals | 12 August 2014 |
| 100 tablet in 1 bottle | 0832-0356-11 | Upsher-Smith laboratories | 17 April 2018 |
| 30 tablet in 1 bottle | 50090-0701-0 | A-S Medication Solutions | 28 November 2014 |
| 30 tablet in 1 bottle | 50090-2153-0 | A-S Medication Solutions | 21 October 2015 |
| 30 tablet in 1 bottle | 50090-8097-0 | A-S Medication Solutions | 5 October 2026 |
| 30 tablet in 1 bottle | 63629-7891-1 | Bryant Ranch Prepack | 5 September 2024 |
| 90 tablet in 1 bottle | 63629-7891-2 | Bryant Ranch Prepack | 11 January 2019 |
| 30 tablet in 1 bottle | 71335-2803-1 | Bryant Ranch Prepack | 13 October 2025 |
| 90 tablet in 1 bottle | 71335-2803-2 | Bryant Ranch Prepack | 13 October 2025 |
| 100 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 68084-836-01 | American Health Packaging | 16 July 2020 |
| 30 blister pack in 1 box, unit-dose / 1 tablet in 1 blister pack | 68084-836-25 | American Health Packaging | 1 February 2016 |
| 50 blister pack in 1 box / 1 tablet in 1 blister pack | 50268-222-15 | AvPAK | 9 May 2022 |
| 100 tablet in 1 bottle | 84677-044-01 | Golden State Medical Supply | 11 May 2026 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-5522-61 | Major Pharmaceuticals | 14 July 2011 |
| 30 tablet in 1 bottle, plastic | 51655-476-52 | Northwind Health | 30 November 2020 |
| 30 tablet in 1 bottle | 68071-4272-3 | NuCare Pharmaceuticals,Inc | 7 February 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 2 November 1990 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Doxazosin 1 mg tablet.
Other strengths and forms of Doxazosin
Clinical summary
Doxazosin is an alpha-adrenergic blocker indicated for signs and symptoms of Benign Prostatic Hyperplasia (BPH), among other approved uses. It is available as tablets and extended-release tablets for oral use. MedsAcross supplies Doxazosin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxazosinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxazosin mesylate prescribing information (Mylan Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Doxazosin 1 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.